Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kinetochores | 42 | 2013 | 194 | 4.580 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 12 | 2017 | 197 | 2.810 |
Why?
|
Models, Biological | 47 | 2022 | 9583 | 2.390 |
Why?
|
Drug Discovery | 10 | 2023 | 1058 | 2.150 |
Why?
|
Chromosome Segregation | 18 | 2011 | 235 | 2.040 |
Why?
|
Signal Transduction | 62 | 2024 | 23403 | 1.780 |
Why?
|
Apoptosis | 30 | 2023 | 9727 | 1.780 |
Why?
|
Neoplasms | 33 | 2023 | 21683 | 1.750 |
Why?
|
Saccharomyces cerevisiae | 38 | 2013 | 2752 | 1.730 |
Why?
|
Melanoma | 14 | 2024 | 5510 | 1.730 |
Why?
|
Software | 19 | 2022 | 4443 | 1.690 |
Why?
|
Antineoplastic Agents | 26 | 2022 | 13695 | 1.570 |
Why?
|
Single-Cell Analysis | 17 | 2023 | 2183 | 1.570 |
Why?
|
Drug Resistance, Neoplasm | 19 | 2023 | 5172 | 1.560 |
Why?
|
Computational Biology | 22 | 2022 | 3521 | 1.540 |
Why?
|
Chromosomal Instability | 4 | 2017 | 184 | 1.540 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2023 | 2043 | 1.530 |
Why?
|
Protein Kinase Inhibitors | 23 | 2023 | 5535 | 1.530 |
Why?
|
Microscopy, Fluorescence | 9 | 2018 | 2699 | 1.430 |
Why?
|
Cell Line, Tumor | 53 | 2023 | 16689 | 1.280 |
Why?
|
MAP Kinase Signaling System | 9 | 2023 | 1526 | 1.280 |
Why?
|
Microtubules | 25 | 2011 | 1090 | 1.260 |
Why?
|
Saccharomyces cerevisiae Proteins | 25 | 2013 | 1888 | 1.250 |
Why?
|
Fungal Proteins | 15 | 2009 | 912 | 1.220 |
Why?
|
Chromosomes, Fungal | 10 | 2013 | 111 | 1.200 |
Why?
|
Data Mining | 3 | 2023 | 537 | 1.170 |
Why?
|
Protein Kinases | 14 | 2024 | 1640 | 1.120 |
Why?
|
Cell Cycle Proteins | 22 | 2020 | 3462 | 1.110 |
Why?
|
Systems Biology | 11 | 2019 | 469 | 1.050 |
Why?
|
Small Molecule Libraries | 5 | 2019 | 720 | 1.050 |
Why?
|
Natural Language Processing | 3 | 2023 | 1041 | 0.950 |
Why?
|
Cell Survival | 19 | 2022 | 5882 | 0.940 |
Why?
|
Gene Expression Regulation, Neoplastic | 14 | 2021 | 8428 | 0.940 |
Why?
|
Proteins | 15 | 2024 | 6103 | 0.930 |
Why?
|
High-Throughput Screening Assays | 7 | 2022 | 944 | 0.920 |
Why?
|
Mitosis | 12 | 2011 | 1208 | 0.870 |
Why?
|
Caspases | 9 | 2023 | 928 | 0.850 |
Why?
|
Respiratory Protective Devices | 2 | 2021 | 45 | 0.840 |
Why?
|
Caspase 8 | 6 | 2015 | 195 | 0.810 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2020 | 10943 | 0.790 |
Why?
|
Indoles | 4 | 2019 | 1839 | 0.780 |
Why?
|
Systems Theory | 3 | 2019 | 60 | 0.780 |
Why?
|
Microscopy | 9 | 2022 | 903 | 0.760 |
Why?
|
Ecosystem | 2 | 2022 | 474 | 0.750 |
Why?
|
Biophysics | 1 | 2021 | 383 | 0.730 |
Why?
|
Epidermal Growth Factor | 8 | 2022 | 708 | 0.720 |
Why?
|
Genes, cdc | 6 | 2005 | 116 | 0.720 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2021 | 200 | 0.720 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.710 |
Why?
|
DNA, Fungal | 10 | 2007 | 280 | 0.710 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 322 | 0.710 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2021 | 538 | 0.700 |
Why?
|
Naphthyridines | 2 | 2019 | 118 | 0.700 |
Why?
|
Humans | 195 | 2024 | 744343 | 0.700 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2020 | 730 | 0.690 |
Why?
|
HeLa Cells | 22 | 2017 | 3128 | 0.690 |
Why?
|
Hepatocytes | 6 | 2017 | 1211 | 0.680 |
Why?
|
Tumor Microenvironment | 15 | 2024 | 3586 | 0.670 |
Why?
|
Aneuploidy | 3 | 2014 | 530 | 0.670 |
Why?
|
Ubiquitin | 2 | 2022 | 852 | 0.640 |
Why?
|
Sulfonamides | 3 | 2017 | 1938 | 0.630 |
Why?
|
Protein Array Analysis | 3 | 2012 | 411 | 0.630 |
Why?
|
Computer Simulation | 20 | 2019 | 6196 | 0.630 |
Why?
|
Synovial Fluid | 2 | 2018 | 394 | 0.630 |
Why?
|
Heat-Shock Proteins | 9 | 2020 | 822 | 0.620 |
Why?
|
Trust | 1 | 2022 | 505 | 0.610 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2020 | 3557 | 0.610 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2021 | 2948 | 0.610 |
Why?
|
Fluorescent Antibody Technique | 7 | 2023 | 2505 | 0.600 |
Why?
|
Programming Languages | 3 | 2013 | 133 | 0.590 |
Why?
|
Zearalenone | 1 | 2016 | 3 | 0.590 |
Why?
|
Computers | 1 | 2019 | 612 | 0.580 |
Why?
|
Cell Physiological Phenomena | 4 | 2020 | 154 | 0.570 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2023 | 8949 | 0.570 |
Why?
|
Proteomics | 15 | 2024 | 3638 | 0.570 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2012 | 4420 | 0.560 |
Why?
|
Kinetics | 15 | 2022 | 6473 | 0.550 |
Why?
|
Staining and Labeling | 3 | 2022 | 1100 | 0.550 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2024 | 2938 | 0.550 |
Why?
|
Nuclear Proteins | 16 | 2011 | 5853 | 0.550 |
Why?
|
Drug Evaluation, Preclinical | 6 | 2018 | 1375 | 0.550 |
Why?
|
Breast Neoplasms | 15 | 2024 | 20822 | 0.540 |
Why?
|
Models, Genetic | 2 | 2017 | 3494 | 0.540 |
Why?
|
Proto-Oncogene Proteins c-akt | 10 | 2024 | 2503 | 0.540 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2017 | 578 | 0.530 |
Why?
|
Centromere | 8 | 2007 | 220 | 0.530 |
Why?
|
Ovarian Neoplasms | 8 | 2022 | 4838 | 0.520 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 11524 | 0.520 |
Why?
|
Cell Cycle | 7 | 2022 | 2967 | 0.520 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2022 | 841 | 0.520 |
Why?
|
Skin Neoplasms | 5 | 2023 | 5686 | 0.510 |
Why?
|
Animals | 76 | 2024 | 168757 | 0.510 |
Why?
|
Synovial Membrane | 2 | 2022 | 507 | 0.510 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8642 | 0.500 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 299 | 0.490 |
Why?
|
Enzyme Activation | 6 | 2012 | 3701 | 0.490 |
Why?
|
Glioblastoma | 5 | 2024 | 3481 | 0.490 |
Why?
|
Proteome | 2 | 2019 | 1799 | 0.490 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 2 | 2011 | 63 | 0.480 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 4 | 2023 | 648 | 0.480 |
Why?
|
Cell Division | 6 | 2020 | 4568 | 0.480 |
Why?
|
Cell Proliferation | 12 | 2022 | 10481 | 0.480 |
Why?
|
Pharmacogenetics | 2 | 2021 | 675 | 0.480 |
Why?
|
Saccharomycetales | 3 | 2011 | 67 | 0.480 |
Why?
|
Fibroblasts | 5 | 2020 | 4161 | 0.470 |
Why?
|
Microtubule-Associated Proteins | 5 | 2009 | 1086 | 0.470 |
Why?
|
Caspase 3 | 3 | 2011 | 758 | 0.470 |
Why?
|
Occupational Exposure | 2 | 2021 | 1796 | 0.470 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2013 | 1157 | 0.460 |
Why?
|
Databases, Protein | 4 | 2021 | 383 | 0.460 |
Why?
|
Stochastic Processes | 2 | 2013 | 344 | 0.460 |
Why?
|
User-Computer Interface | 3 | 2019 | 1431 | 0.440 |
Why?
|
DNA-Binding Proteins | 17 | 2012 | 9648 | 0.440 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2013 | 1660 | 0.440 |
Why?
|
Lymphoma, B-Cell | 1 | 2019 | 931 | 0.440 |
Why?
|
Cell Death | 4 | 2015 | 1706 | 0.440 |
Why?
|
Research Design | 3 | 2022 | 5987 | 0.430 |
Why?
|
Receptors, Growth Factor | 1 | 2013 | 334 | 0.430 |
Why?
|
Sequence Deletion | 1 | 2017 | 1526 | 0.420 |
Why?
|
Microchip Analytical Procedures | 3 | 2008 | 29 | 0.420 |
Why?
|
Neurogenesis | 1 | 2019 | 838 | 0.420 |
Why?
|
Neural Stem Cells | 2 | 2019 | 851 | 0.420 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2021 | 671 | 0.410 |
Why?
|
Cell Line | 17 | 2023 | 15997 | 0.410 |
Why?
|
Cell Biology | 1 | 2012 | 92 | 0.410 |
Why?
|
Clinical Trials as Topic | 4 | 2022 | 7913 | 0.400 |
Why?
|
Calcium-Binding Proteins | 6 | 2011 | 1081 | 0.400 |
Why?
|
Models, Theoretical | 5 | 2016 | 3589 | 0.390 |
Why?
|
Nerve Tissue Proteins | 3 | 2021 | 4462 | 0.390 |
Why?
|
Carrier Proteins | 6 | 2005 | 5021 | 0.380 |
Why?
|
Biochemistry | 2 | 2011 | 113 | 0.380 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1676 | 0.380 |
Why?
|
Pharmacology, Clinical | 1 | 2010 | 21 | 0.370 |
Why?
|
Software Design | 1 | 2011 | 176 | 0.370 |
Why?
|
Drug Therapy, Combination | 4 | 2022 | 6489 | 0.370 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 4 | 2023 | 625 | 0.370 |
Why?
|
Mutation | 20 | 2023 | 29786 | 0.370 |
Why?
|
Biochemical Phenomena | 1 | 2010 | 59 | 0.370 |
Why?
|
Oncogenes | 4 | 2023 | 1265 | 0.370 |
Why?
|
Adaptation, Physiological | 2 | 2020 | 1312 | 0.370 |
Why?
|
Chromosomes | 4 | 2007 | 596 | 0.370 |
Why?
|
Database Management Systems | 2 | 2011 | 270 | 0.370 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 407 | 0.370 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1637 | 0.370 |
Why?
|
Schizosaccharomyces | 2 | 2011 | 237 | 0.360 |
Why?
|
Plaque, Amyloid | 1 | 2014 | 729 | 0.360 |
Why?
|
Pharmacological Phenomena | 1 | 2009 | 11 | 0.360 |
Why?
|
Computer Graphics | 2 | 2022 | 361 | 0.360 |
Why?
|
Cluster Analysis | 8 | 2019 | 2715 | 0.350 |
Why?
|
Drug Synergism | 4 | 2019 | 1792 | 0.350 |
Why?
|
Phosphorylation | 16 | 2021 | 8436 | 0.350 |
Why?
|
Oncogene Proteins v-erbB | 1 | 2009 | 17 | 0.340 |
Why?
|
Fluorescent Dyes | 3 | 2015 | 1917 | 0.340 |
Why?
|
Mitochondrial Membranes | 4 | 2011 | 175 | 0.340 |
Why?
|
Intracellular Signaling Peptides and Proteins | 8 | 2020 | 2915 | 0.330 |
Why?
|
Enzymes | 1 | 2010 | 266 | 0.330 |
Why?
|
Gene Expression Profiling | 12 | 2021 | 9438 | 0.330 |
Why?
|
Cell Membrane | 2 | 2020 | 3748 | 0.330 |
Why?
|
Chromosomes, Human | 2 | 2011 | 457 | 0.320 |
Why?
|
MAP Kinase Kinase Kinases | 3 | 2016 | 261 | 0.320 |
Why?
|
Cells | 1 | 2009 | 168 | 0.320 |
Why?
|
Molecular Motor Proteins | 2 | 2006 | 107 | 0.320 |
Why?
|
Arthritis, Rheumatoid | 3 | 2022 | 3712 | 0.310 |
Why?
|
Fuzzy Logic | 4 | 2012 | 56 | 0.310 |
Why?
|
Pyrimidinones | 2 | 2020 | 371 | 0.310 |
Why?
|
Information Dissemination | 1 | 2016 | 1099 | 0.310 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1736 | 0.310 |
Why?
|
Research Personnel | 1 | 2012 | 573 | 0.300 |
Why?
|
Antibodies | 3 | 2019 | 2460 | 0.300 |
Why?
|
Cytokines | 9 | 2022 | 7322 | 0.300 |
Why?
|
Mammals | 3 | 2023 | 1143 | 0.300 |
Why?
|
DNA Damage | 8 | 2023 | 2432 | 0.290 |
Why?
|
Biological Products | 1 | 2016 | 860 | 0.290 |
Why?
|
Yeasts | 4 | 2003 | 285 | 0.290 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1339 | 0.290 |
Why?
|
Stress, Physiological | 1 | 2014 | 1403 | 0.290 |
Why?
|
Luminescent Proteins | 4 | 2008 | 853 | 0.290 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 592 | 0.280 |
Why?
|
Mice | 31 | 2024 | 81183 | 0.280 |
Why?
|
Drug Industry | 1 | 2012 | 746 | 0.280 |
Why?
|
Cytosol | 4 | 2018 | 901 | 0.280 |
Why?
|
BRCA1 Protein | 3 | 2022 | 1149 | 0.280 |
Why?
|
Gene Regulatory Networks | 4 | 2021 | 1708 | 0.270 |
Why?
|
HEK293 Cells | 6 | 2020 | 4204 | 0.270 |
Why?
|
Autocrine Communication | 2 | 2006 | 171 | 0.270 |
Why?
|
Adenomatous Polyposis Coli Protein | 2 | 2006 | 188 | 0.270 |
Why?
|
Gene Expression Regulation, Fungal | 4 | 2009 | 502 | 0.270 |
Why?
|
Inhibitory Concentration 50 | 2 | 2017 | 459 | 0.270 |
Why?
|
Pyrazoles | 4 | 2020 | 1972 | 0.270 |
Why?
|
Reproducibility of Results | 15 | 2023 | 19905 | 0.270 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2021 | 234 | 0.260 |
Why?
|
Pandemics | 5 | 2021 | 8388 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
Ubiquitination | 3 | 2022 | 1012 | 0.260 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6364 | 0.260 |
Why?
|
Bayes Theorem | 2 | 2013 | 2309 | 0.260 |
Why?
|
Phosphotransferases | 2 | 2021 | 308 | 0.250 |
Why?
|
Cysteine | 2 | 2020 | 874 | 0.250 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2214 | 0.250 |
Why?
|
Algorithms | 17 | 2022 | 13881 | 0.250 |
Why?
|
Phosphoproteins | 8 | 2021 | 2440 | 0.240 |
Why?
|
Protein-Tyrosine Kinases | 5 | 2020 | 2455 | 0.240 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2020 | 2109 | 0.240 |
Why?
|
Receptor, erbB-3 | 2 | 2017 | 142 | 0.240 |
Why?
|
Genes | 4 | 1989 | 1893 | 0.230 |
Why?
|
Chromatids | 2 | 2001 | 63 | 0.230 |
Why?
|
Pharmaceutical Preparations | 2 | 2011 | 1071 | 0.230 |
Why?
|
Anaphase | 5 | 2013 | 120 | 0.230 |
Why?
|
Flow Cytometry | 6 | 2019 | 5974 | 0.230 |
Why?
|
Diagnostic Imaging | 3 | 2023 | 3507 | 0.230 |
Why?
|
Receptor, erbB-2 | 4 | 2020 | 2416 | 0.230 |
Why?
|
Immunoconjugates | 2 | 2024 | 901 | 0.230 |
Why?
|
Information Storage and Retrieval | 3 | 2017 | 824 | 0.230 |
Why?
|
Protein Binding | 15 | 2021 | 9386 | 0.220 |
Why?
|
Genomic Instability | 3 | 2021 | 695 | 0.220 |
Why?
|
Databases, Factual | 6 | 2023 | 7729 | 0.220 |
Why?
|
Cell Culture Techniques | 3 | 2019 | 1678 | 0.220 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6773 | 0.220 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 3 | 2007 | 168 | 0.220 |
Why?
|
Endopeptidases | 2 | 2022 | 772 | 0.220 |
Why?
|
Furans | 1 | 2024 | 194 | 0.220 |
Why?
|
Ketones | 1 | 2024 | 188 | 0.220 |
Why?
|
Protein Interaction Mapping | 4 | 2017 | 627 | 0.220 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2018 | 697 | 0.220 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2023 | 121 | 0.220 |
Why?
|
Genes, Fungal | 3 | 1995 | 455 | 0.220 |
Why?
|
Protein Conformation | 7 | 2022 | 4011 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 5 | 2011 | 4042 | 0.210 |
Why?
|
Brain Neoplasms | 2 | 2020 | 8863 | 0.210 |
Why?
|
Macromolecular Substances | 7 | 2004 | 1454 | 0.210 |
Why?
|
Tubulin Modulators | 3 | 2011 | 110 | 0.210 |
Why?
|
Molecular Sequence Data | 17 | 2009 | 18111 | 0.210 |
Why?
|
Amino Acid Sequence | 17 | 2020 | 13815 | 0.210 |
Why?
|
Enzyme Inhibitors | 5 | 2017 | 3798 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 3 | 2022 | 6538 | 0.210 |
Why?
|
Linear Models | 3 | 2019 | 5952 | 0.200 |
Why?
|
Rhabdoid Tumor | 1 | 2024 | 212 | 0.200 |
Why?
|
src Homology Domains | 3 | 2021 | 364 | 0.200 |
Why?
|
Gene Deletion | 3 | 2008 | 2751 | 0.200 |
Why?
|
Thiolester Hydrolases | 1 | 2022 | 86 | 0.200 |
Why?
|
Hemangiosarcoma | 1 | 2024 | 239 | 0.200 |
Why?
|
Circadian Clocks | 1 | 2024 | 171 | 0.200 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2013 | 92 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2023 | 4479 | 0.200 |
Why?
|
Cells, Cultured | 10 | 2019 | 19229 | 0.200 |
Why?
|
NF-kappa B | 3 | 2018 | 2499 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2015 | 1434 | 0.190 |
Why?
|
Indicators and Reagents | 1 | 2002 | 462 | 0.190 |
Why?
|
Liposarcoma | 1 | 2024 | 333 | 0.190 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 2 | 2012 | 59 | 0.190 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.190 |
Why?
|
Glutarates | 1 | 2022 | 236 | 0.190 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1692 | 0.190 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2916 | 0.190 |
Why?
|
Receptor, Insulin | 2 | 2019 | 846 | 0.190 |
Why?
|
Decontamination | 1 | 2021 | 69 | 0.190 |
Why?
|
Knowledge Bases | 1 | 2021 | 85 | 0.190 |
Why?
|
Lung Neoplasms | 8 | 2024 | 13102 | 0.190 |
Why?
|
Phenotype | 12 | 2022 | 16365 | 0.190 |
Why?
|
Mitochondrial Proteins | 2 | 2022 | 996 | 0.190 |
Why?
|
Immunotherapy | 6 | 2023 | 4445 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9239 | 0.190 |
Why?
|
Ligands | 4 | 2022 | 3282 | 0.180 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2020 | 57 | 0.180 |
Why?
|
Models, Statistical | 3 | 2022 | 5102 | 0.180 |
Why?
|
Mice, Nude | 5 | 2019 | 3689 | 0.180 |
Why?
|
Protein Transport | 3 | 2018 | 1988 | 0.180 |
Why?
|
Molecular Structure | 6 | 2020 | 1899 | 0.180 |
Why?
|
Quinazolines | 3 | 2011 | 1356 | 0.180 |
Why?
|
Sterilization | 1 | 2021 | 133 | 0.180 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1177 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2020 | 191 | 0.180 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2022 | 871 | 0.180 |
Why?
|
Transcription Factor CHOP | 1 | 2019 | 73 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2020 | 112 | 0.180 |
Why?
|
Nootropic Agents | 1 | 2021 | 160 | 0.180 |
Why?
|
Cystadenoma, Serous | 1 | 2020 | 102 | 0.180 |
Why?
|
Leiomyosarcoma | 1 | 2024 | 477 | 0.180 |
Why?
|
Tumor Cells, Cultured | 7 | 2021 | 6314 | 0.170 |
Why?
|
Karyotyping | 3 | 2014 | 1243 | 0.170 |
Why?
|
Receptors, Somatomedin | 1 | 2019 | 57 | 0.170 |
Why?
|
Sarcoma, Synovial | 1 | 2021 | 167 | 0.170 |
Why?
|
Cell Movement | 3 | 2019 | 5217 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 360 | 0.170 |
Why?
|
Models, Chemical | 1 | 2021 | 626 | 0.170 |
Why?
|
Chromosomal Proteins, Non-Histone | 5 | 2008 | 736 | 0.170 |
Why?
|
Cell Line, Transformed | 2 | 2011 | 898 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 449 | 0.170 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2019 | 19 | 0.170 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.170 |
Why?
|
Structure-Activity Relationship | 5 | 2020 | 3129 | 0.170 |
Why?
|
Pyrimidines | 4 | 2021 | 2942 | 0.170 |
Why?
|
Acrylamide | 1 | 2019 | 60 | 0.170 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2727 | 0.170 |
Why?
|
Ventilators, Mechanical | 1 | 2021 | 292 | 0.170 |
Why?
|
Masks | 1 | 2021 | 197 | 0.170 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2019 | 96 | 0.170 |
Why?
|
Acclimatization | 1 | 2019 | 103 | 0.170 |
Why?
|
Cerebellar Neoplasms | 1 | 2024 | 587 | 0.170 |
Why?
|
Drugs, Investigational | 1 | 2021 | 214 | 0.160 |
Why?
|
Green Fluorescent Proteins | 5 | 2011 | 2088 | 0.160 |
Why?
|
Cataloging | 1 | 2017 | 8 | 0.160 |
Why?
|
Female | 37 | 2024 | 380194 | 0.160 |
Why?
|
Immunity | 2 | 2023 | 1012 | 0.160 |
Why?
|
Stem Cell Niche | 1 | 2021 | 346 | 0.160 |
Why?
|
Ascites | 1 | 2020 | 344 | 0.160 |
Why?
|
Frontotemporal Dementia | 1 | 2021 | 248 | 0.160 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8037 | 0.160 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 973 | 0.160 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2022 | 450 | 0.160 |
Why?
|
Extracellular Space | 1 | 2020 | 594 | 0.150 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 835 | 0.150 |
Why?
|
RNA Interference | 5 | 2013 | 2889 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3920 | 0.150 |
Why?
|
Protein Processing, Post-Translational | 3 | 2012 | 1990 | 0.150 |
Why?
|
Azepines | 1 | 2019 | 336 | 0.150 |
Why?
|
Sirtuin 3 | 1 | 2018 | 68 | 0.150 |
Why?
|
Transcription, Genetic | 8 | 2020 | 7722 | 0.150 |
Why?
|
Meiosis | 2 | 2011 | 339 | 0.150 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2018 | 123 | 0.150 |
Why?
|
Macrophages | 6 | 2020 | 5655 | 0.150 |
Why?
|
Phosphotyrosine | 2 | 2021 | 457 | 0.150 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2019 | 337 | 0.150 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 731 | 0.150 |
Why?
|
Uncertainty | 1 | 2022 | 734 | 0.150 |
Why?
|
Tumor Necrosis Factors | 2 | 2023 | 109 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 2 | 2019 | 783 | 0.150 |
Why?
|
src-Family Kinases | 1 | 2020 | 551 | 0.150 |
Why?
|
Hot Temperature | 4 | 1991 | 1354 | 0.150 |
Why?
|
BRCA2 Protein | 1 | 2022 | 794 | 0.140 |
Why?
|
Time Factors | 10 | 2017 | 40075 | 0.140 |
Why?
|
Feedback, Physiological | 3 | 2009 | 479 | 0.140 |
Why?
|
Anilides | 1 | 2020 | 408 | 0.140 |
Why?
|
Drug Interactions | 2 | 2020 | 1460 | 0.140 |
Why?
|
Permeability | 2 | 2009 | 738 | 0.140 |
Why?
|
Evolution, Molecular | 2 | 2021 | 1940 | 0.140 |
Why?
|
Myeloid Cells | 1 | 2021 | 810 | 0.140 |
Why?
|
ras Proteins | 2 | 2020 | 1060 | 0.140 |
Why?
|
Inflammation | 4 | 2020 | 10638 | 0.140 |
Why?
|
Cell Nucleus | 2 | 2022 | 2969 | 0.140 |
Why?
|
Receptor, IGF Type 1 | 2 | 2019 | 390 | 0.140 |
Why?
|
Neoplasm Transplantation | 2 | 2017 | 2085 | 0.140 |
Why?
|
Recombination, Genetic | 1 | 2021 | 1586 | 0.140 |
Why?
|
Uveal Neoplasms | 1 | 2019 | 310 | 0.140 |
Why?
|
Repressor Proteins | 6 | 2021 | 3023 | 0.140 |
Why?
|
Amides | 1 | 2019 | 459 | 0.140 |
Why?
|
RNA | 3 | 2024 | 2749 | 0.140 |
Why?
|
F-Box Proteins | 1 | 1997 | 197 | 0.140 |
Why?
|
Brain Edema | 1 | 2020 | 617 | 0.140 |
Why?
|
Protease Inhibitors | 1 | 2020 | 791 | 0.140 |
Why?
|
Ubiquitins | 1 | 1997 | 384 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5221 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 349 | 0.130 |
Why?
|
Base Sequence | 11 | 2016 | 12797 | 0.130 |
Why?
|
Nocodazole | 3 | 2011 | 97 | 0.130 |
Why?
|
Cricetulus | 1 | 2017 | 816 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 1 | 2024 | 895 | 0.130 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2015 | 49 | 0.130 |
Why?
|
Stromal Cells | 2 | 2018 | 1355 | 0.130 |
Why?
|
Receptors, Death Domain | 1 | 2015 | 32 | 0.130 |
Why?
|
Chromosome Aberrations | 3 | 2014 | 1813 | 0.130 |
Why?
|
Craniopharyngioma | 1 | 2018 | 281 | 0.130 |
Why?
|
Insulin | 5 | 2024 | 6580 | 0.130 |
Why?
|
Transcription Factors | 6 | 2021 | 12208 | 0.130 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10180 | 0.130 |
Why?
|
Nucleotides | 1 | 2018 | 464 | 0.130 |
Why?
|
Pattern Recognition, Automated | 1 | 2021 | 1005 | 0.130 |
Why?
|
Mitochondria | 4 | 2013 | 3520 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.130 |
Why?
|
Centrosome | 2 | 2008 | 201 | 0.120 |
Why?
|
CHO Cells | 1 | 2017 | 1406 | 0.120 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2021 | 643 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2014 | 1723 | 0.120 |
Why?
|
Cisplatin | 1 | 2020 | 1662 | 0.120 |
Why?
|
Lab-On-A-Chip Devices | 3 | 2008 | 428 | 0.120 |
Why?
|
Frizzled Receptors | 1 | 2014 | 91 | 0.120 |
Why?
|
Thalidomide | 1 | 2019 | 890 | 0.120 |
Why?
|
HT29 Cells | 5 | 2005 | 200 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2017 | 601 | 0.120 |
Why?
|
Genomics | 7 | 2024 | 5720 | 0.120 |
Why?
|
S Phase | 2 | 2013 | 423 | 0.120 |
Why?
|
Coloring Agents | 1 | 2016 | 566 | 0.120 |
Why?
|
Neuroprotective Agents | 1 | 2021 | 941 | 0.120 |
Why?
|
Drug Delivery Systems | 3 | 2017 | 2219 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1511 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2021 | 595 | 0.120 |
Why?
|
Epithelial Cells | 1 | 2006 | 3690 | 0.120 |
Why?
|
Databases, Genetic | 1 | 2021 | 1783 | 0.120 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2013 | 75 | 0.110 |
Why?
|
Internet | 3 | 2021 | 3064 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 5 | 2008 | 3772 | 0.110 |
Why?
|
Fas Ligand Protein | 1 | 2014 | 216 | 0.110 |
Why?
|
Dexamethasone | 1 | 2020 | 1951 | 0.110 |
Why?
|
Lymphoma | 1 | 2022 | 1877 | 0.110 |
Why?
|
G2 Phase | 2 | 2007 | 139 | 0.110 |
Why?
|
Protein Structure, Tertiary | 4 | 2014 | 3846 | 0.110 |
Why?
|
Observer Variation | 1 | 2019 | 2593 | 0.110 |
Why?
|
Recombinant Proteins | 4 | 2011 | 6622 | 0.110 |
Why?
|
Data Collection | 1 | 2022 | 3341 | 0.110 |
Why?
|
Chromatin | 3 | 2001 | 2934 | 0.110 |
Why?
|
Neuregulin-1 | 1 | 2013 | 142 | 0.110 |
Why?
|
Retinal Diseases | 1 | 2019 | 683 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.110 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2021 | 990 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.110 |
Why?
|
Cloning, Molecular | 5 | 1999 | 4320 | 0.110 |
Why?
|
Language | 2 | 2022 | 1471 | 0.110 |
Why?
|
Cell Differentiation | 3 | 2020 | 11483 | 0.110 |
Why?
|
Maturation-Promoting Factor | 1 | 1992 | 26 | 0.110 |
Why?
|
Sarcoma | 1 | 2024 | 1897 | 0.110 |
Why?
|
Pyrroles | 1 | 2019 | 1146 | 0.110 |
Why?
|
bcl-2-Associated X Protein | 1 | 2013 | 295 | 0.110 |
Why?
|
Membrane Proteins | 3 | 2018 | 7880 | 0.110 |
Why?
|
Potoroidae | 1 | 2011 | 7 | 0.100 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2012 | 452 | 0.100 |
Why?
|
False Positive Reactions | 1 | 2014 | 981 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
Cell Count | 1 | 2016 | 1856 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
Cyclin B | 1 | 2011 | 108 | 0.100 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4253 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 3 | 2013 | 4554 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2020 | 2942 | 0.100 |
Why?
|
Molecular Probes | 1 | 2013 | 316 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2421 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1584 | 0.100 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3703 | 0.100 |
Why?
|
Dimerization | 4 | 2014 | 893 | 0.100 |
Why?
|
Inflammation Mediators | 2 | 2011 | 1889 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2019 | 3327 | 0.100 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 12072 | 0.100 |
Why?
|
Chromosomes, Mammalian | 1 | 2011 | 151 | 0.100 |
Why?
|
STAT Transcription Factors | 2 | 2023 | 182 | 0.100 |
Why?
|
Phylogeny | 3 | 2021 | 2803 | 0.100 |
Why?
|
Clone Cells | 1 | 2014 | 1692 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.090 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2014 | 651 | 0.090 |
Why?
|
Protein Subunits | 4 | 2007 | 959 | 0.090 |
Why?
|
Peptides | 2 | 2020 | 4409 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1414 | 0.090 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 440 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1654 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 2866 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 1988 | 0.090 |
Why?
|
Calibration | 1 | 2013 | 816 | 0.090 |
Why?
|
Medical Oncology | 1 | 2022 | 2265 | 0.090 |
Why?
|
Gene Dosage | 1 | 2014 | 1252 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1378 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.090 |
Why?
|
Binding Sites | 3 | 2012 | 6114 | 0.090 |
Why?
|
Adenosine Triphosphate | 2 | 2013 | 2025 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1345 | 0.090 |
Why?
|
Transcriptional Activation | 3 | 2013 | 1783 | 0.090 |
Why?
|
Hair | 1 | 2013 | 483 | 0.090 |
Why?
|
Apoptosomes | 1 | 2008 | 4 | 0.090 |
Why?
|
Crystallography, X-Ray | 5 | 2016 | 2011 | 0.080 |
Why?
|
Centromere Protein B | 1 | 2008 | 4 | 0.080 |
Why?
|
Sequence Alignment | 3 | 2022 | 2256 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1580 | 0.080 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2015 | 1338 | 0.080 |
Why?
|
Paraffin Embedding | 2 | 2019 | 299 | 0.080 |
Why?
|
Caspase 9 | 1 | 2008 | 188 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2011 | 1547 | 0.080 |
Why?
|
Paclitaxel | 3 | 2011 | 1708 | 0.080 |
Why?
|
Substrate Specificity | 2 | 2019 | 1801 | 0.080 |
Why?
|
Antibodies, Neutralizing | 2 | 2020 | 1978 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 1997 | 1861 | 0.080 |
Why?
|
Formaldehyde | 2 | 2019 | 353 | 0.080 |
Why?
|
HCT116 Cells | 2 | 2019 | 408 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 871 | 0.080 |
Why?
|
Biophysical Phenomena | 2 | 2020 | 327 | 0.080 |
Why?
|
Heterozygote | 1 | 2014 | 2804 | 0.080 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1254 | 0.080 |
Why?
|
Glioma | 1 | 2022 | 3401 | 0.070 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1991 | 794 | 0.070 |
Why?
|
Cell Communication | 3 | 2017 | 1621 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12354 | 0.070 |
Why?
|
Biomedical Research | 2 | 2016 | 3309 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2004 | 1364 | 0.070 |
Why?
|
Plant Viruses | 1 | 1986 | 40 | 0.070 |
Why?
|
Mice, Knockout | 5 | 2021 | 14557 | 0.070 |
Why?
|
Nondisjunction, Genetic | 1 | 2006 | 24 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 903 | 0.070 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 401 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3527 | 0.070 |
Why?
|
Cells, Immobilized | 1 | 2006 | 36 | 0.070 |
Why?
|
Mathematics | 1 | 2008 | 728 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2968 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.070 |
Why?
|
Drug Therapy | 1 | 2009 | 497 | 0.070 |
Why?
|
DNA Primers | 2 | 2005 | 2892 | 0.070 |
Why?
|
Metaphase | 1 | 2006 | 151 | 0.070 |
Why?
|
Stimulation, Chemical | 1 | 2006 | 326 | 0.070 |
Why?
|
Drug Approval | 1 | 2012 | 742 | 0.070 |
Why?
|
Models, Molecular | 4 | 2020 | 5456 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 2015 | 0.070 |
Why?
|
Receptor Cross-Talk | 1 | 2006 | 119 | 0.070 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2126 | 0.070 |
Why?
|
beta Catenin | 1 | 2011 | 1059 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 4 | 2018 | 1285 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2013 | 828 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2009 | 14722 | 0.070 |
Why?
|
United States | 5 | 2021 | 69872 | 0.070 |
Why?
|
RNA Viruses | 1 | 1986 | 124 | 0.070 |
Why?
|
Lamin Type A | 1 | 2006 | 190 | 0.070 |
Why?
|
Plasma | 1 | 2008 | 575 | 0.060 |
Why?
|
Interleukin-1 | 2 | 2006 | 1263 | 0.060 |
Why?
|
Molecular Biology | 2 | 2010 | 596 | 0.060 |
Why?
|
Clathrin | 1 | 1986 | 267 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2009 | 2839 | 0.060 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18029 | 0.060 |
Why?
|
DNA | 3 | 2002 | 7301 | 0.060 |
Why?
|
Drug Design | 2 | 2021 | 1076 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1987 | 404 | 0.060 |
Why?
|
Membrane Potentials | 1 | 2008 | 1137 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2010 | 972 | 0.060 |
Why?
|
Hormones | 1 | 2008 | 889 | 0.060 |
Why?
|
Liver | 2 | 2011 | 7474 | 0.060 |
Why?
|
Organ Specificity | 1 | 2009 | 2008 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1038 | 0.060 |
Why?
|
Crosses, Genetic | 1 | 2005 | 791 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1504 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2023 | 3206 | 0.060 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5867 | 0.060 |
Why?
|
Benzamides | 3 | 2018 | 1379 | 0.060 |
Why?
|
Autoantigens | 1 | 2008 | 892 | 0.060 |
Why?
|
Environment | 1 | 2010 | 1124 | 0.060 |
Why?
|
Macaca mulatta | 2 | 2020 | 2375 | 0.060 |
Why?
|
Growth Substances | 1 | 2006 | 784 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1097 | 0.060 |
Why?
|
Blood Proteins | 1 | 2008 | 1124 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2505 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 77 | 0.060 |
Why?
|
Genes, Dominant | 1 | 2006 | 880 | 0.060 |
Why?
|
ARNTL Transcription Factors | 1 | 2024 | 98 | 0.060 |
Why?
|
Claudins | 1 | 2024 | 111 | 0.060 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2005 | 563 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 2 | 2002 | 1375 | 0.060 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2541 | 0.060 |
Why?
|
Microfluidics | 1 | 2008 | 662 | 0.060 |
Why?
|
Neurons | 2 | 2021 | 9338 | 0.060 |
Why?
|
Prognosis | 5 | 2022 | 29063 | 0.060 |
Why?
|
Blotting, Western | 2 | 2014 | 5179 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4851 | 0.050 |
Why?
|
Blastocyst | 1 | 2005 | 424 | 0.050 |
Why?
|
Piperidines | 2 | 2021 | 1602 | 0.050 |
Why?
|
Jurkat Cells | 2 | 2019 | 743 | 0.050 |
Why?
|
Multiprotein Complexes | 4 | 2012 | 1119 | 0.050 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 252 | 0.050 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 789 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 244 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2011 | 3420 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2171 | 0.050 |
Why?
|
Mutagenesis | 3 | 1999 | 1266 | 0.050 |
Why?
|
Species Specificity | 1 | 2006 | 2478 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 424 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 437 | 0.050 |
Why?
|
Biflavonoids | 1 | 2021 | 12 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 160 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4420 | 0.050 |
Why?
|
DNA Repeat Expansion | 1 | 2021 | 66 | 0.050 |
Why?
|
Genetic Variation | 2 | 2014 | 6544 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1801 | 0.050 |
Why?
|
Equipment Reuse | 1 | 2021 | 41 | 0.050 |
Why?
|
Poly A | 1 | 2021 | 185 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 377 | 0.050 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2021 | 49 | 0.050 |
Why?
|
Phospholipase C gamma | 1 | 2021 | 128 | 0.050 |
Why?
|
Spheroids, Cellular | 1 | 2023 | 351 | 0.050 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2020 | 86 | 0.050 |
Why?
|
Monocytes | 1 | 2010 | 2596 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 829 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2022 | 276 | 0.050 |
Why?
|
Gene Library | 2 | 2017 | 1074 | 0.050 |
Why?
|
Bronchoalveolar Lavage | 1 | 2020 | 120 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2024 | 63114 | 0.050 |
Why?
|
Butadienes | 2 | 2010 | 110 | 0.050 |
Why?
|
Janus Kinase 1 | 1 | 2020 | 104 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2012 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9849 | 0.050 |
Why?
|
Phase Transition | 1 | 2020 | 74 | 0.040 |
Why?
|
Immunoblotting | 1 | 2003 | 1682 | 0.040 |
Why?
|
G1 Phase | 2 | 1999 | 415 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4386 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 290 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 373 | 0.040 |
Why?
|
Trans-Activators | 1 | 1989 | 2924 | 0.040 |
Why?
|
raf Kinases | 1 | 2019 | 122 | 0.040 |
Why?
|
Stem Cells | 1 | 2013 | 3567 | 0.040 |
Why?
|
Catalysis | 1 | 2021 | 761 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2002 | 708 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2013 | 6171 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2023 | 5524 | 0.040 |
Why?
|
Peptide Mapping | 1 | 1999 | 263 | 0.040 |
Why?
|
DNA Replication | 1 | 2006 | 1399 | 0.040 |
Why?
|
Pheromones | 1 | 1999 | 98 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 40561 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 2020 | 165 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1880 | 0.040 |
Why?
|
Disinfection | 1 | 2021 | 191 | 0.040 |
Why?
|
Wnt Proteins | 2 | 2014 | 721 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2021 | 229 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2020 | 236 | 0.040 |
Why?
|
Tissue Fixation | 1 | 2019 | 241 | 0.040 |
Why?
|
Azaserine | 1 | 2018 | 7 | 0.040 |
Why?
|
Complement Activation | 1 | 2020 | 453 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2022 | 618 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 2020 | 270 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1992 | 1085 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 289 | 0.040 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2005 | 828 | 0.040 |
Why?
|
Elasticity | 1 | 2000 | 657 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12745 | 0.040 |
Why?
|
Microscopy, Electron | 3 | 2005 | 2645 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2005 | 2373 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 849 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 768 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2022 | 781 | 0.040 |
Why?
|
Guanosine Diphosphate | 1 | 1997 | 85 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2001 | 2050 | 0.040 |
Why?
|
Mitogens | 1 | 2018 | 232 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.040 |
Why?
|
Phototherapy | 1 | 2021 | 377 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 21827 | 0.040 |
Why?
|
Adenosine | 1 | 2022 | 825 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2020 | 373 | 0.040 |
Why?
|
Information Theory | 1 | 2017 | 51 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 363 | 0.040 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1999 | 337 | 0.040 |
Why?
|
Molecular Weight | 2 | 1990 | 2255 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2021 | 581 | 0.040 |
Why?
|
Organoids | 1 | 2023 | 701 | 0.040 |
Why?
|
Microsomes, Liver | 1 | 2016 | 173 | 0.040 |
Why?
|
Guanosine Triphosphate | 1 | 1997 | 321 | 0.040 |
Why?
|
Biological Transport | 1 | 2001 | 2118 | 0.040 |
Why?
|
Platelet Activation | 1 | 2020 | 673 | 0.040 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2018 | 443 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2216 | 0.030 |
Why?
|
Ligases | 1 | 1997 | 333 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 728 | 0.030 |
Why?
|
Up-Regulation | 2 | 2018 | 4217 | 0.030 |
Why?
|
DNA Footprinting | 1 | 1995 | 98 | 0.030 |
Why?
|
Interferon Type I | 1 | 2019 | 542 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1213 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2020 | 598 | 0.030 |
Why?
|
Temperature | 3 | 2007 | 2206 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 890 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1063 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 981 | 0.030 |
Why?
|
Endocytosis | 1 | 2020 | 985 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
Drug Resistance | 1 | 2021 | 1609 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.030 |
Why?
|
Nitriles | 2 | 2010 | 956 | 0.030 |
Why?
|
Glutamine | 1 | 2018 | 578 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 430 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1997 | 694 | 0.030 |
Why?
|
Image Enhancement | 1 | 2005 | 2921 | 0.030 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 34 | 0.030 |
Why?
|
Selection, Genetic | 1 | 1999 | 914 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 1997 | 913 | 0.030 |
Why?
|
National Health Programs | 1 | 2017 | 445 | 0.030 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2016 | 252 | 0.030 |
Why?
|
Least-Squares Analysis | 2 | 2005 | 379 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39050 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1850 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 780 | 0.030 |
Why?
|
Topoisomerase Inhibitors | 1 | 2013 | 18 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1607 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 956 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1348 | 0.030 |
Why?
|
Spodoptera | 2 | 2005 | 153 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 712 | 0.030 |
Why?
|
Breast | 1 | 2022 | 1969 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11366 | 0.030 |
Why?
|
Fatty Acids | 1 | 2020 | 1809 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1994 | 315 | 0.030 |
Why?
|
Ion Channels | 1 | 2017 | 1056 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3479 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2624 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2003 | 4803 | 0.030 |
Why?
|
Virus Replication | 1 | 2020 | 2534 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 2013 | 547 | 0.030 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 808 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 1941 | 0.030 |
Why?
|
Lung | 2 | 2020 | 9856 | 0.030 |
Why?
|
Immobilized Proteins | 1 | 2011 | 25 | 0.020 |
Why?
|
Time-Lapse Imaging | 1 | 2012 | 195 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3299 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4186 | 0.020 |
Why?
|
Movement | 1 | 1998 | 1471 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 1992 | 220 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1807 | 0.020 |
Why?
|
Computers, Molecular | 1 | 2010 | 14 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2013 | 431 | 0.020 |
Why?
|
Child | 3 | 2024 | 77709 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57776 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 279 | 0.020 |
Why?
|
Diphenylamine | 1 | 2010 | 50 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 474 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 873 | 0.020 |
Why?
|
Logic | 1 | 2010 | 39 | 0.020 |
Why?
|
U937 Cells | 1 | 2010 | 268 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 104 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2011 | 393 | 0.020 |
Why?
|
Clarithromycin | 1 | 2010 | 86 | 0.020 |
Why?
|
Culture Media | 1 | 2012 | 908 | 0.020 |
Why?
|
Interleukins | 1 | 2014 | 791 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2488 | 0.020 |
Why?
|
Male | 7 | 2021 | 350118 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 733 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3176 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 494 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3778 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2013 | 749 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1341 | 0.020 |
Why?
|
Rats | 3 | 2011 | 24260 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2011 | 905 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3597 | 0.020 |
Why?
|
Antigens, CD | 1 | 2019 | 4026 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Microspheres | 1 | 2011 | 777 | 0.020 |
Why?
|
Feedback | 1 | 1992 | 795 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2009 | 862 | 0.020 |
Why?
|
Fluoroquinolones | 1 | 2010 | 310 | 0.020 |
Why?
|
Tyrosine | 1 | 1992 | 1461 | 0.020 |
Why?
|
Antimitotic Agents | 1 | 2007 | 30 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12951 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 1986 | 313 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2649 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2007 | 195 | 0.020 |
Why?
|
Cell Extracts | 1 | 2006 | 138 | 0.020 |
Why?
|
Oocytes | 1 | 2011 | 1187 | 0.020 |
Why?
|
Transforming Growth Factor alpha | 1 | 2005 | 135 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2203 | 0.020 |
Why?
|
Crystallization | 1 | 1986 | 524 | 0.020 |
Why?
|
Education | 1 | 2008 | 543 | 0.020 |
Why?
|
Middle Aged | 4 | 2020 | 213383 | 0.020 |
Why?
|
Genes, ras | 1 | 2007 | 690 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2021 | 5708 | 0.020 |
Why?
|
Brain | 2 | 2021 | 26385 | 0.010 |
Why?
|
Capsid | 1 | 1986 | 436 | 0.010 |
Why?
|
Multigene Family | 1 | 2007 | 1102 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3870 | 0.010 |
Why?
|
Cricetinae | 1 | 1987 | 2472 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2016 | 3479 | 0.010 |
Why?
|
Aged | 3 | 2020 | 163280 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
Buffers | 1 | 2002 | 147 | 0.010 |
Why?
|
Immunoassay | 1 | 2006 | 752 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 264 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 972 | 0.010 |
Why?
|
Plasmids | 1 | 1987 | 2307 | 0.010 |
Why?
|
Surface Properties | 1 | 2005 | 1184 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3339 | 0.010 |
Why?
|
Solutions | 1 | 2002 | 426 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5181 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 1246 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 1991 | 1703 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1986 | 2557 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2002 | 683 | 0.010 |
Why?
|
Electrons | 1 | 2002 | 268 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2849 | 0.010 |
Why?
|
Pyridines | 1 | 2012 | 2825 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29144 | 0.010 |
Why?
|
Biological Assay | 1 | 2003 | 652 | 0.010 |
Why?
|
Micrococcal Nuclease | 1 | 1999 | 37 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11031 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5892 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9734 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2006 | 1741 | 0.010 |
Why?
|
Galactose | 1 | 1999 | 306 | 0.010 |
Why?
|
RNA, Viral | 1 | 1986 | 2902 | 0.010 |
Why?
|
Peptide Library | 1 | 1999 | 349 | 0.010 |
Why?
|
Hydrolysis | 1 | 1997 | 682 | 0.010 |
Why?
|
Lipoproteins | 1 | 1999 | 878 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
Tubulin | 1 | 1997 | 695 | 0.010 |
Why?
|
Polymers | 1 | 1997 | 1621 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12245 | 0.010 |
Why?
|
Sepsis | 1 | 2003 | 2593 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.000 |
Why?
|
Adult | 1 | 2020 | 214055 | 0.000 |
Why?
|